Wasatch Advisors Inc Novartis Ag Transaction History

Wasatch Advisors Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 07, 2018	SELL	$66.94 - $77.43 $2.63 Million - $3.04 Million	-39,273 Closed	0 $0
Q1 2018 May 02, 2018	SELL	$70.39 - $84.15 $28,296 - $33,828	-402 Reduced 1.01%	39,273 $0
Q4 2017 Jan 16, 2018	BUY	$72.33 - $77.64 $2,893 - $3,105	40 Added 0.1%	39,675 $0
Q3 2017 Nov 08, 2017	BUY	$74.14 - $77.27 $5,708 - $5,949	77 Added 0.19%	39,635 $0
Q2 2017 Aug 16, 2017	BUY	N/A	39,558	39,558 $0

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $209B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Wasatch Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Wasatch Advisors Inc with notifications on news.